Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 12.75 +1.74 (15.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.01 | 52 Week High | $9.23 | |||
| Open | $11.17 | 52 Week Low | $1.16 | |||
| Day High | $13.04 | P/E | N/A | |||
| Day Low | $11.03 | EPS | $-0.30 | |||
| Volume | 19,019,175 | |||||
